Pepticom Ltd.
Pepticom uses artificial intelligence to accelerate discovery of peptide molecules for pharmaceutical, agricultural, and animal health uses. The company runs a B2B platform built on machine-learning prediction models originating from research at the Hebrew University to design and prioritize peptide candidates. Its tooling combines predictive AI models and in-silico screening to reduce lab time and focus experimental validation for research centers, pharma companies, and agribusiness partners. Pepticom’s platform has supported discovery programs across metabolic disease and immuno-modulation and is applied to both drug and agricultural peptide projects.
Pepticom Ltd.
Pepticom uses artificial intelligence to accelerate discovery of peptide molecules for pharmaceutical, agricultural, and animal health uses. The company runs a B2B platform built on machine-learning prediction models originating from research at the Hebrew University to design and prioritize peptide candidates. Its tooling combines predictive AI models and in-silico screening to reduce lab time and focus experimental validation for research centers, pharma companies, and agribusiness partners. Pepticom’s platform has supported discovery programs across metabolic disease and immuno-modulation and is applied to both drug and agricultural peptide projects.